The role of the respiratory physiotherapist in the management of Duchenne muscular dystrophy.

IF 4.5 Q2 RESPIRATORY SYSTEM
Breathe Pub Date : 2026-09-15 eCollection Date: 2026-07-01 DOI:10.1183/20734735.0044-2026
Claire Egan
{"title":"The role of the respiratory physiotherapist in the management of Duchenne muscular dystrophy.","authors":"Claire Egan","doi":"10.1183/20734735.0044-2026","DOIUrl":null,"url":null,"abstract":"<p><p>Patients with Duchenne muscular dystrophy (DMD) are living longer, mostly due to the combined contribution of corticosteroids and advances in cardiopulmonary interventions. However, respiratory complications are a major cause of morbidity and unplanned hospital admissions. While the widespread use of noninvasive ventilation has reduced respiratory mortality, it remains a major contributor to death in DMD, alongside cardiac causes. There is an expanding pipeline of therapies aimed at restoring dystrophin function or compensating for dysfunction in development; however, there is currently no curative treatment for DMD. Respiratory failure is inevitable as this disease progresses; therefore, maintaining respiratory health is essential to prolonging survival and quality of life in this patient population. Respiratory physiotherapy should be considered if there are concerns about cough strength, ability to manage respiratory secretions or frequent chest infections. Techniques such as breathstacking and lung volume recruitment can help to offset the effects of inspiratory muscle weakness, and assisted coughing can help to correct the effects of expiratory muscle weakness. Mechanical insufflation-exsufflation can maximise cough effectiveness in the presence of both inspiratory and expiratory muscle weakness. Treatments should be anticipatory and proactive in approach to slow the decline of respiratory muscle function and aim to prevent respiratory morbidity. Given the time spent with patients assessing and introducing therapies, physiotherapists are uniquely placed to work with patients and their families and caregivers in developing positive relationships between them and the interventions employed. It is imperative that patients are empowered to be involved in the introduction of these therapies, as adherence with noninvasive ventilation and airway clearance strategies needs to be lifelong and is essential to their success.</p>","PeriodicalId":9292,"journal":{"name":"Breathe","volume":"22 3","pages":"260044"},"PeriodicalIF":4.5000,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13579355/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breathe","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/20734735.0044-2026","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Patients with Duchenne muscular dystrophy (DMD) are living longer, mostly due to the combined contribution of corticosteroids and advances in cardiopulmonary interventions. However, respiratory complications are a major cause of morbidity and unplanned hospital admissions. While the widespread use of noninvasive ventilation has reduced respiratory mortality, it remains a major contributor to death in DMD, alongside cardiac causes. There is an expanding pipeline of therapies aimed at restoring dystrophin function or compensating for dysfunction in development; however, there is currently no curative treatment for DMD. Respiratory failure is inevitable as this disease progresses; therefore, maintaining respiratory health is essential to prolonging survival and quality of life in this patient population. Respiratory physiotherapy should be considered if there are concerns about cough strength, ability to manage respiratory secretions or frequent chest infections. Techniques such as breathstacking and lung volume recruitment can help to offset the effects of inspiratory muscle weakness, and assisted coughing can help to correct the effects of expiratory muscle weakness. Mechanical insufflation-exsufflation can maximise cough effectiveness in the presence of both inspiratory and expiratory muscle weakness. Treatments should be anticipatory and proactive in approach to slow the decline of respiratory muscle function and aim to prevent respiratory morbidity. Given the time spent with patients assessing and introducing therapies, physiotherapists are uniquely placed to work with patients and their families and caregivers in developing positive relationships between them and the interventions employed. It is imperative that patients are empowered to be involved in the introduction of these therapies, as adherence with noninvasive ventilation and airway clearance strategies needs to be lifelong and is essential to their success.

呼吸物理治疗师在杜氏肌营养不良症治疗中的作用。
杜氏肌营养不良症(DMD)患者的寿命更长,主要是由于皮质类固醇和心肺干预技术的进步。然而,呼吸道并发症是发病和意外住院的主要原因。虽然无创通气的广泛使用降低了呼吸系统死亡率,但它仍然是DMD死亡的主要原因,与心脏原因并列。旨在恢复肌营养不良蛋白功能或补偿发育障碍的疗法正在不断扩大;然而,目前还没有治愈DMD的方法。随着病情的发展,呼吸衰竭是不可避免的;因此,维持呼吸系统健康对于延长患者的生存和生活质量至关重要。如果担心咳嗽强度、控制呼吸道分泌物的能力或频繁的胸部感染,应考虑呼吸物理治疗。呼吸叠加和肺容量增加等技术可以帮助抵消吸气肌无力的影响,辅助咳嗽可以帮助纠正呼气肌无力的影响。在吸气和呼气肌无力的情况下,机械吸气-呼气可以最大限度地提高咳嗽效果。治疗应具有预见性和前瞻性,以减缓呼吸肌功能的衰退,防止呼吸道疾病的发生。考虑到与患者一起评估和介绍治疗方法所花费的时间,物理治疗师在与患者及其家属和护理人员一起工作方面具有独特的地位,可以在他们与所采用的干预措施之间建立积极的关系。患者有权参与这些疗法的引入是必要的,因为坚持无创通气和气道清除策略需要终生,这对他们的成功至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Breathe
Breathe RESPIRATORY SYSTEM-
CiteScore
2.90
自引率
5.00%
发文量
51
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书